The causal association between lipid-lowering drug targets and albuminuria risk: A drug-target Mendelian randomization study
Journal of Clinical Lipidology · 2026-06 · 20 (6) · 1144-1155
DOI: 10.1016/j.jacl.2026.04.020 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Lipidology, 2026-06. Verfasst von Daihui Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Tianjin Key Lab of Functional Imaging & Tianjin Institute of Radiology, Tianjin Medical University General Hospital, Tianjin…. Hauptthemen laut MEDLINE: Albuminuria, Mendelian Randomization Analysis, Hypolipidemic Agents. Die Arbeit nennt 37 Literaturangaben. Gefördert von: Tianjin Municipal Science and Technology Program.
Abstract (Originalsprache)
BACKGROUND Lipid-lowering therapies may attenuate kidney disease progression; however, whether specific lipid-lowering drug targets exert causal effects on albuminuria, which is an early marker of kidney injury, remains unclear. OBJECTIVE To assess whether lipid-lowering drugs causally influence albuminuria risk and explore potential mediating pathways. METHODS We conducted drug-target Mendelian randomization (MR) for 4 targets (lipoprotein lipase [LPL], peroxisome proliferator-activated receptor alpha [PPARA], 3-hydroxy-3-methylglutaryl-coenzyme A reductase [HMGCR], proprotein convertase subtilisin/kexin type 9 [PCSK9]) using 2 complementary approaches. Summary data-based MR (SMR) leveraged cis-expression quantitative trait loci to proxy target-gene expression, whereas cis-MR used lipid-associated cis variants to proxy target perturbation. Albuminuria summary statistics were obtained from CKDGen (cases: urinary albumin-to-creatinine ratio [UACR] >30 mg/g; controls: UACR
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Tianjin Key Lab of Functional Imaging & Tianjin Institute of Radiology, Tianjin Medical University General Hospital, Tianjin, China (Zhang, Li, Hu, Liu, Jiayuan Xu, Qiang Xu, and Wang); Departme…
- Department of Radiology, Tianjin Key Lab of Functional Imaging & Tianjin Institute of Radiology, Tianjin Medical University General Hospital, Tianjin, China (Zhang, Li, Hu, Liu, Jiayuan Xu, Qiang Xu, and Wang).
- Cardiovascular and Vascular Surgery, Xingtai Central Hospital, Xingtai, Hebei, China (Guo).
- Department of Radiology, Tianjin Key Lab of Functional Imaging & Tianjin Institute of Radiology, Tianjin Medical University General Hospital, Tianjin, China (Zhang, Li, Hu, Liu, Jiayuan Xu, Qiang Xu, and Wang). Electron…
Förderung
- Tianjin Municipal Science and Technology Program
Zitieren
APA
Zhang, D., Li, H., Hu, W., Guo, L., Liu, Z., Xu, J., Xu, Q., & Wang, J. (2026). The causal association between lipid-lowering drug targets and albuminuria risk: A drug-target Mendelian randomization study. Journal of Clinical Lipidology, 20(6), 1144-1155. https://doi.org/10.1016/j.jacl.2026.04.020
Vancouver
Zhang D, Li H, Hu W, Guo L, Liu Z, Xu J, et al. The causal association between lipid-lowering drug targets and albuminuria risk: A drug-target Mendelian randomization study. Journal of Clinical Lipidology. 2026;20(6):1144-1155. doi:10.1016/j.jacl.2026.04.020
BibTeX
@article{Zhang2026,
author = {Zhang, Daihui and Li, Haonan and Hu, Weijie and Guo, Lixin and Liu, Zhixuan and Xu, Jiayuan and Xu, Qiang and Wang, Junping},
title = {The causal association between lipid-lowering drug targets and albuminuria risk: A drug-target Mendelian randomization study},
journal = {Journal of Clinical Lipidology},
year = {2026},
volume = {20},
number = {6},
pages = {1144--1155},
doi = {10.1016/j.jacl.2026.04.020}
}
EUVIMED